Skip to main content

Table 3 Multivariate analysis of overall survival in stage I–III endometrial cancer patients

From: Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study

CovariateOverall survival
95% CIHazard ratioP value
Pathological type0.03
 Endometrioid 
 Non-endometrioid1.133–6.8392.784 
Myometrial invasion1.139–6.4002.7000.02
Ovarian metastasis1.603–50.4778.9940.01
Lymph node metastasis3.708–25.2459.675< 0.01
Adjuvant therapy0.18
 No0.06
 Chemotherapy0.857–329.21016.7920.03
 Radiotherapy1.376–760.36632.3500.15
 Both0.422–342.52912.024 
  1. OR odds ratio, CI confidence interval, LVSI lymphovascular space invasion
  2. A P value of < 0.05 was considered to be statistically significant
  3. Conferent: pathological type (endometrioid); myometrial invasion (< 50%); ovarian metastasis (−); lymph node metastasis (−); adjuvant therapy (no adjuvant therapy)